Cell Growth & Differentiation, Vol 3, Issue 2 101-109, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Transforming growth factor beta modulates phosphorylation of the epidermal growth factor receptor and proliferation of A431 cells

T Goldkorn and J Mendelsohn
Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

Transforming growth factor beta (TGF-beta) increased the phosphorylation of the epidermal growth factor (EGF) receptor and inhibited the growth of A431 cells. Incubation with TGF-beta induced maximal EGF receptor phosphorylation to levels 1.5-fold higher than controls. Phosphorylation increased more prominently (4-5-fold) on tyrosine residues as determined by phosphoamino acid analysis and antiphosphotyrosine antibody immunoblotting. The kinase activity of EGF receptor was also elevated 2.5-fold when cells were cultured in the presence of TGF-beta. The antiproliferative effect of TGF-beta on A431 cells was accompanied by prolongation of G0-G1 phase and by morphological changes. TGF-beta augmented the growth inhibition of A431 cells which could be induced by EGF. In parallel, the specific EGF-induced increase in total phosphorylation of the EGF receptor was also augmented in the presence of TGF-beta. In cells cultured with TGF-beta, the phosphorylation of EGF receptor tyrosines induced by 20-min exposure to EGF was further increased 2-3-fold, suggesting additive effects upon receptor phosphorylation. EGF receptor activation by TGF-beta is characterized by kinetics quite distinct from that induced by EGF and therefore appears to take place through an independent mechanism. The TGF-beta-induced elevation in the phosphorylation of the EGF receptor may have a role in the augmented growth inhibition of A431 cells observed in the presence of EGF and TGF-beta.

This article has been cited by other articles:

				J. He and H. E. P. Bazan Epidermal Growth Factor Synergism with TGF-{beta}1 via PI-3 Kinase Activity in Corneal Keratocyte Differentiation Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2936 - 2945. [Abstract] [Full Text] [PDF]

				K. Mimori, K. Yamashita, M. Ohta, K. Yoshinaga, K. Ishikawa, H. Ishii, T. Utsunomiya, G. F. Barnard, H. Inoue, and M. Mori Coexpression of Matrix Metalloproteinase-7 (MMP-7) and Epidermal Growth Factor (EGF) Receptor in Colorectal Cancer: An EGF Receptor Tyrosine Kinase Inhibitor Is Effective against MMP-7-Expressing Cancer Cells Clin. Cancer Res., December 15, 2004; 10(24): 8243 - 8249. [Abstract] [Full Text] [PDF]

				A. van der Vliet, M. Hristova, C. E. Cross, J. P. Eiserich, and T. Goldkorn Peroxynitrite Induces Covalent Dimerization of Epidermal Growth Factor Receptors in A431 Epidermoid Carcinoma Cells J. Biol. Chem., November 27, 1998; 273(48): 31860 - 31866. [Abstract] [Full Text] [PDF]

				T. Goldkorn, N. Balaban, K. Matsukuma, V. Chea, R. Gould, J. Last, C. Chan, and C. Chavez EGF-Receptor Phosphorylation and Signaling Are Targeted by H2O2 Redox Stress Am. J. Respir. Cell Mol. Biol., November 1, 1998; 19(5): 786 - 798. [Abstract] [Full Text]